Trial Profile
Phase 2 Study of Exemestane in Advanced and Recurrent Endometrial Carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Exemestane (Primary)
- Indications Carcinoma; Endometrial cancer
- Focus Therapeutic Use
- 27 Oct 2013 New trial record